GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

ShareHope Medicine Co 8403.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

18.60

+4.79%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 4.36bn

FY2016FY2025

Net income

TWD 141.7m

FY2016FY2025

Free cash flow

TWD 232.3m

FY2016FY2025

Shareholders' equity

TWD 3.44bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 4.36bnTWD 4.33bnTWD 3.87bnTWD 4.14bnTWD 3.85bnTWD 4.10bnTWD 3.12bnTWD 3.06bnTWD 2.62bnTWD 2.33bn
Gross profitTWD 709.0mTWD 714.4mTWD 726.4mTWD 983.9mTWD 834.0mTWD 1.18bnTWD 652.9mTWD 648.5mTWD 604.3mTWD 440.4m
Research and developmentTWD 5.6mTWD 11.8mTWD 12.3mTWD 16.4m——————
Operating incomeTWD 175.3mTWD 189.4mTWD 165.7mTWD 376.1mTWD 272.2mTWD 496.5mTWD 139.0mTWD 84.2mTWD 174.6mTWD 160.4m
Net incomeTWD 141.7mTWD 200.1mTWD 124.6mTWD 293.9mTWD 232.7mTWD 247.7mTWD 195.1mTWD 145.9mTWD 124.4mTWD 123.4m
Diluted earnings per share1.121.570.972.332.042.171.531.150.981.05

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 6.62bnTWD 7.10bnTWD 7.45bnTWD 7.38bnTWD 6.11bnTWD 5.69bnTWD 4.21bnTWD 3.85bnTWD 3.36bnTWD 3.10bn
Cash and short-term investments——TWD 1.43bnTWD 1.55bnTWD 1.57bnTWD 1.72bn———TWD 559.7m
Total liabilitiesTWD 2.78bnTWD 3.12bnTWD 3.49bnTWD 3.28bnTWD 2.23bnTWD 2.11bnTWD 1.51bnTWD 1.29bnTWD 1.31bnTWD 1.30bn
DebtTWD 811.7mTWD 825.2mTWD 2.28bnTWD 2.11bnTWD 1.31bnTWD 1.05bnTWD 114.0mTWD 264.7mTWD 172.4mTWD 488.0m
Shareholders' equityTWD 3.44bnTWD 3.56bnTWD 3.49bnTWD 3.42bnTWD 3.15bnTWD 2.92bnTWD 2.51bnTWD 2.36bnTWD 1.86bnTWD 1.81bn
Shares outstanding127m127m128m126m114m114m127m127m127m117m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 364.1mTWD 266.7mTWD 257.1mTWD 642.5mTWD 360.1mTWD 717.7mTWD 502.6mTWD 33.9mTWD 62.8mTWD 168.3m
Capital spending−TWD 131.8m−TWD 93.0m−TWD 277.2m−TWD 1.28bn−TWD 152.3m−TWD 364.0m−TWD 104.2m−TWD 102.3m−TWD 177.9m−TWD 137.7m
Free cash flowTWD 232.3mTWD 173.7m−TWD 20.1m−TWD 641.6mTWD 207.8mTWD 353.7mTWD 398.5m−TWD 68.4m−TWD 115.2mTWD 30.6m
Dividends paid−TWD 68.6m−TWD 53.9m−TWD 62.4m−TWD 59.3m−TWD 102.8m−TWD 2.1m−TWD 48.7m−TWD 46.4m−TWD 37.0m−TWD 110.2m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 1.19bnTWD 1.08bnTWD 1.13bnTWD 1.11bnTWD 1.07bnTWD 1.05bnTWD 1.11bnTWD 1.15bn
Gross profitTWD 209.4mTWD 148.5mTWD 174.8mTWD 184.6mTWD 175.5mTWD 174.1mTWD 171.1mTWD 174.5m
Operating income—TWD 18.1mTWD 76.4mTWD 53.3mTWD 37.2mTWD 32.9mTWD 82.9mTWD 20.8m
Net incomeTWD 61.5mTWD 17.8mTWD 51.8mTWD 31.0mTWD 27.9mTWD 31.0mTWD 87.7mTWD 16.7m
Diluted earnings per share0.480.140.410.240.220.240.690.13
Cash from operationsTWD 154.0mTWD 28.0mTWD 113.0mTWD 110.0mTWD 176.0m−TWD 36.0mTWD 60.0mTWD 66.0m
Capital spending−TWD 21.0m−TWD 15.0m−TWD 39.0m−TWD 15.0m−TWD 46.0m−TWD 30.0m−TWD 37.0m−TWD 19.0m
Free cash flowTWD 133.0mTWD 13.0mTWD 74.0mTWD 95.0mTWD 130.0m−TWD 66.0mTWD 23.0mTWD 47.0m
Total assetsTWD 6.54bnTWD 6.53bnTWD 6.62bnTWD 6.76bnTWD 6.73bnTWD 6.84bnTWD 7.10bnTWD 7.12bn
DebtTWD 786.5mTWD 806.6mTWD 811.7mTWD 828.5mTWD 831.6mTWD 878.5mTWD 825.2mTWD 929.1m
Shareholders' equityTWD 3.30bnTWD 3.42bnTWD 3.44bnTWD 3.61bnTWD 3.51bnTWD 3.55bnTWD 3.56bnTWD 3.52bn

Financial ratios

Data as of 23 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin16.3%16.5%18.8%23.8%21.7%28.8%
Operating margin4.5%5.4%4.3%9.1%7.1%12.1%
Net margin3.3%4.6%3.2%7.1%6.0%6.0%
Return on equity4.1%5.6%3.6%8.6%7.4%8.5%
Return on assets2.1%2.8%1.7%4.0%3.8%4.4%
Free cash flow yield—15.0%22.1%80.9%23.7%50.1%
Revenue growth0.7%11.7%-6.4%7.5%-6.1%31.2%
Earnings growth-29.2%60.6%-57.6%26.3%-6.1%27.0%
Current ratio2.00x1.82x1.65x1.85x2.14x1.91x
Debt to equity0.24x0.23x0.52x0.46x0.22x0.28x
Equity ratio52.1%50.1%46.8%46.3%51.5%51.3%
Interest coverage4.14x3.98x3.09x9.86x13.52x34.19x
R&D as a share of sales0.1%0.3%0.3%0.4%——
Buybacks as a share of market value—0.6%-1.4%-10.2%-0.2%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue1.7%1.2%7.4%
Operating income-22.5%-18.8%2.8%
Net income-21.6%-10.6%-4.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin16.4%18.8%20.9%20.9%
Operating margin4.2%5.4%6.8%6.2%
Net margin3.9%4.6%5.0%5.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings20.917.530.912.611.012.714.716.125.421.1
Price to sales0.70.81.00.90.70.80.90.81.21.1

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 26 Aug 2025.

FY2025FY2024FY2023FY2022
Paid in the year0.500.3810.4580.436
  • 1049-for-1000 split · 26 Aug 2025
  • 1050-for-1000 split · 25 Aug 2025
  • 1040-for-1000 split · 27 Aug 2024
  • 1050-for-1000 split · 29 Aug 2023
  • 1050-for-1000 split · 30 Aug 2022
  • 1050-for-1000 split · 16 Sept 2021

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.